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Abstract
Background
Hemorrhage is a leading cause of death after trauma and childbirth. In response to severe
hemorrhage, bleeding patients often receive transfusions of red blood cells, plasma, plate-
lets, or other blood components. We examined risk factors for transfusion in acute severe
bleeding in two trials of over 20,000 patients to better understand factors associated with
transfusion likelihood.
Study design and methods
We conducted a cohort analysis of data from the CRASH-2 and WOMAN trials, two multina-
tional trials that recruited patients with traumatic and postpartum hemorrhage, respectively.
For each trial, we examined the effect of 10 factors on blood transfusion likelihood. Univari-
ate and multivariate Poisson regressions were used to analyze the relationship between risk
factors and blood transfusion.
Results
Of the 20,207 traumatic hemorrhage patients, 10,232 (51%) received blood components. Of
the 20,060 women with postpartum hemorrhage, 10,958 (55%) received blood components.
For patients who suffered from traumatic hemorrhage, those greater than three hours from
injury to hospitalization were more likely to be transfused (ARR 1.37; 95% CI, 1.20–1.56).
Postpartum hemorrhage patients had an increased likelihood of transfusion if they gave
birth outside the hospital (ARR 1.30; 95% CI 1.22–1.39), gave birth more than three hours
before hospitalization (ARR 1.09; 95% CI 1.01–1.17), had a Caesarean section (ARR 1.16;
95% CI 1.08–1.25), and if they had any identifiable causes of hemorrhage other than uterine
atony.
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Conclusion
Several risk factors are associated with an increased likelihood of transfusion in traumatic
and postpartum hemorrhage patients. Altering modifiable factors, by reducing time from
injury or childbirth to hospitalization, for example, might be able to reduce transfusions and
their complications.
Trial registration
CRASH-2 is registered as ISRCTN86750102, ClinicalTrials.gov NCT00375258 and South
African Clinical Trial Register DOH-27–0607–1919. WOMAN is registered as
ISRCTN76912190, ClinicalTrials.gov NCT00872469, PACTR201007000192283, and
EudraCT number 2008-008441-38.
Introduction
World-wide about 10% of deaths are due to trauma. Deaths from trauma disproportionately
affect people in lower income countries, with more than 90% of deaths due to injury occurring
in low- and middle-income countries [1,2]. Approximately 40% of trauma deaths are due to
bleeding, making hemorrhage the leading cause of death following injury [3]. Appropriate
management of traumatic bleeding includes rapid identification of bleeding sources, followed
by immediate measures to stem blood loss and restore hemodynamic stability [4]. Trauma
patients who require massive transfusion or develop coagulopathy have poor outcomes [5,6].
Postpartum hemorrhage, typically defined as blood loss�500 mL within 24 hours of birth,
is also a substantial cause of mortality. Postpartum hemorrhage occurs in about 6% of all child-
births and is responsible for up to 100,000 deaths each year (approximately one quarter of all
maternal deaths) [7,8]. Risk factors for postpartum hemorrhage include prolonged third stage
of labor, multiple births, fetal macrosomia, episiotomy and previous postpartum hemorrhage
[9,10]. Almost all (99%) maternal hemorrhage deaths are in low and middle income countries
[11].
Blood transfusions are often given to replace blood lost after traumatic and postpartum
hemorrhage [12,13]. However, in low-income countries there is a limited supply of safe blood
for transfusion [14]. Due to transfusion transmitted infections, low donation rates, sub-opti-
mal management of blood stocks and inadequate distribution of blood, many low- and mid-
dle-income countries are unable to meet transfusion demand [15,16]. To better understand
how both hemodynamic and non-hemodynamic risk factors influence transfusion likelihood,
we assessed the risk factors associated with likelihood of transfusion in two large, previously-
published multinational trials.
Materials and methods
Study design
The institutional review board of the London School of Hygiene & Tropical Medicine
approved this study. This is a retrospective analysis of two randomized controlled trials. The
details of the trial protocol and approval are published and publicly available. Data were ana-
lyzed anonymously.
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The CRASH-2 trial was a randomized placebo-controlled trial of tranexamic acid in 20,207
bleeding trauma patients conducted in 274 hospitals in 40 countries [17]. Adult trauma
patients with or at risk of acute significant hemorrhage, defined as hemorrhage within 8 hours
of the injury, were randomly allocated to receive tranexamic acid or placebo. Baseline data
were recorded prior to randomization. Outcome data were recorded at discharge from the
randomizing hospital, 28 days after injury, or death, whichever came first [18].
The WOMAN trial was a randomized double-blind, placebo-controlled trial of tranexamic
acid in 20,060 women with postpartum hemorrhage that was conducted in 193 hospitals in 21
countries. Women aged 16 years or older with a diagnosis of postpartum hemorrhage after
vaginal birth or caesarean section were randomly allocated to tranexamic acid or placebo. The
diagnosis of postpartum hemorrhage was clinical (estimated blood loss�500 mL after vaginal
birth or�1000 mL after caesarean section). Baseline data were recorded prior to randomiza-
tion. Outcome data were recorded at discharge from the randomizing hospital, 42 days after
giving birth or death, whichever came first [19,20]. Neither the CRASH-2 trial nor the
WOMAN trial found a significant difference in the incidence of transfusion by trial arm.
For the cohort analyses, the study outcome was defined as any blood component transfusion
(whole or packed red blood cells, fresh frozen plasma, and other blood components). The expo-
sure country income level, measured by gross national income per capita for each country, was
classified according to the World Bank 2017 system, using the Atlas method (see appendix).
The World Bank’s method for classifying country income levels allows for inter-country income
comparisons. The Atlas method reduces fluctuations in exchange rates by using a three-year
moving average, price adjusted conversion factor [21]. For trauma patients, potential risk fac-
tors were systolic blood pressure, age, sex, Glasgow Coma Score, injury type, respiratory rate,
heart rate, capillary refill time, use of tranexamic acid, and time from injury to randomization
(a proxy for the time elapsed from injury to the diagnosis of hemorrhage) [22,23]. For women
with postpartum hemorrhage, potential risk factors were systolic blood pressure, age, hospital
childbirth, type of birth, placenta fully expelled, primary cause of hemorrhage, estimated blood
loss, clinical signs of hemodynamic instability, use of tranexamic acid, and time from childbirth
to randomization (a proxy for the time elapsed from delivery to the diagnosis of postpartum
hemorrhage) [24,25]. The adjustments for use of tranexamic acid were used as a sensitivity anal-
ysis to determine if the randomized intervention also acted as a risk factor.
Statistics
For statistical analyses, we used Stata 14 and R, version 3.4.3. A priori, we created subgroups
for risk factors and outcomes based on commonly-used strata for each factor. To show the fre-
quency distribution of blood component transfusions, we prepared histograms of blood trans-
fusion volumes by country income group. We cross tabulated exposures and outcome,
including both missing and present data. For variables with more than 1% missing data, we
explored baseline characteristics of participants with missing data to understand how partici-
pants with and without missing data differed. We conducted univariate analyses to examine
risk factors for transfusion. To avoid the possibility of failed convergence with the log-bino-
mial model, we used a robust, correlation-adjusted Poisson model to estimate relative risks
[26,27]. Univariate robust effects Poisson models were used to calculate crude risk ratios,
adjusted for clustering of subjects by hospital. A backwards approach was used to create a mul-
tivariate correlation-adjusted Poisson model. Variables were individually removed from the
model to assess for confounding and collinearity. To produce our multivariate model, we con-
trolled for all variables of interest, including factors indicative of bleeding severity. Hemody-
namic factors were determined based on a pathophysiological understanding of the
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mechanisms of hemorrhage. For the CRASH-2 trial, variables reflective of bleeding severity
were systolic blood pressure, Glasgow Coma Score, respiratory rate, heart rate, and capillary
refill time. For the WOMAN trial, variables reflective of hemodynamic status were systolic
blood pressure, estimated blood loss, and clinical signs of hemodynamic instability. We also
examined the association between country income level and the receipt of single unit blood
component transfusions to better understand how factors such as low blood supplies in low
income countries affect the receipt of blood transfusions.
Results
Trauma patients
Table 1 shows the characteristics of the 20,207 participants included in the CRASH-2 trial. 10,232
(51%) participants were transfused with blood components. Average time from injury to random-
ization was 3.3 hours, with 37% (7,478) in the�1 hour group. In this cohort, 16,935 (84%) partici-
pants were male, 13,692 (68%) had systolic blood pressure�90 mmHg, and 12,132 (60%) were
recruited from lower-middle-income countries. The average age of study participants was 34.6
years. The frequencies of blood transfusion for high-income, upper-middle-income, lower-mid-
dle-income, and low-income countries were 80%, 54%, 48%, and 72%, respectively. For those
who were transfused with blood components, the volume of blood components transfused dif-
fered by country income group (Fig 1). With decreasing country income level, the frequency of
single unit blood transfusions increased: high-income (3%), upper-middle-income (13%), lower-
middle-income (22%), and low-income (28%). Patients with blunt and penetrating injury were
more likely to receive a transfusion than patients with blunt injury alone (RR 1.18; 95% CI 1.03–
1.36). In univariate analyses, age and sex did not affect transfusion likelihood. Compared with
patients with systolic blood pressure�90 mmHg, those with a systolic blood pressure�90
mmHg had an increased risk of blood transfusion. Of the risk factors included in this study, only
one had>1% missing data. 611 (3%) patients were missing data on capillary refill time, and they
had a higher risk of transfusion than participants without missing data (RR 1.12; 95% CI 1.04–
1.20). Only 80 participants (<1%) had missing data on blood component transfusion.
To control for confounding, we calculated adjusted risk ratios (ARR). Relative to patients in
high-income countries, patients in lower-middle-income countries were less likely to receive a
blood component transfusion (ARR 0.66; 95% CI 0.55–0.80). The decreased frequency of
blood transfusion in lower income countries was evident even for blood transfusions greater
than one unit (Table 2). Analyses of single unit blood transfusion indicated increasing likeli-
hood of single unit blood transfusion with decreasing country income level. Relative to
patients in high-income countries, traumatic hemorrhage patients in low-income countries
had over 10 times the risk of single unit blood transfusion (ARR 10.04; 95% CI 4.06–24.82).
After adjustment, there was some evidence that female sex was associated with an increased
risk of blood transfusion (ARR 1.05; 95% CI 1.00–1.10). The adjusted relative risks for time
from injury to randomization were 1.25 (95% CI, 1.12–1.40) in patients in the 1–3 hour group
and 1.37 (95% CI, 1.20–1.56) for patients in the>3 hour group. Adjusting for all variables,
blunt and penetrating injury were associated with a 12% greater risk of transfusion when com-
pared to blunt injury alone. Amongst hemodynamic factors, the greatest likelihood of transfu-
sion was for patients with systolic blood pressure�75 (ARR 1.53; 95% CI 1.41–1.65) and for
patients with heart rate >107 (ARR 1.37; 95% CI 1.25–1.51).
Women with postpartum hemorrhage
Table 3 shows data for the 20,060 women enrolled in the WOMAN trial. Of the study partici-
pants, 10,958 (55%) received blood component transfusions. Time from childbirth to
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Table 1. Analysis of risk factors for blood transfusion in traumatic hemorrhage patients.
Variable Total Blood component transfusion (% transfused) Crude risk ratio (95% CI) Adjusted risk ratio� (95% CI)
Country income group†
High 417 (2.1%) 381 (80.0%) 1 1
Upper-middle 7594 (37.6%) 4039 (53.5%) 0.65 (0.58–0.72) 0.78 (0.66–0.91)
Lower-middle 12132 (60.0%) 5766 (47.9%) 0.58 (0.49–0.68) 0.66 (0.55–0.80)
Low 64 (0.3%) 46 (71.9%) 0.87 (0.82–0.91) 0.73 (0.63–0.85)
Age (years)
<25 5638 (27.9%) 2810 (50.0%) 1 1
25–34 6093 (30.2%) 3105 (51.1%) 1.02 (0.97–1.07) 1.01 (0.97–1.05)
35–44 3816 (18.9%) 1953 (51.4%) 1.03 (0.97–1.09) 1.00 (0.96–1.04)
>44 4656 (23.0%) 2363 (51.0%) 1.02 (0.94–1.10) 0.98 (0.92–1.04)
Unknown 4 (<0.1%)
Sex
Male 16935 (83.8%) 8493 (50.4%) 1 1
Female 3271 (16.2%) 1738 (53.4%) 1.06 (0.99–1.14) 1.05 (1.00–1.10)
Unknown 1 (<0.1%)
Time since injury (h)
�1 7478 (37.0%) 3248 (43.6%) 1 1
1–3 6051 (30.0%) 3263 (54.1%) 1.24 (1.08–1.43) 1.25 (1.12–1.40)
>3 6667 (33.0%) 3715 (56.0%) 1.28 (1.10–1.50) 1.37 (1.20–1.56)
Unknown 11 (<0.1%)
Injury type
Blunt 11189 (55.4%) 5557 (49.8%) 1 1
Penetrating 6552 (32.4%) 3229 (49.5%) 0.99 (0.88–1.12) 1.01 (0.92–1.11)
Blunt and penetrating 2466 (12.2%) 1446 (59.0%) 1.18 (1.03–1.36) 1.12 (1.00–1.25)
Systolic blood pressure (mmHg)
�90 13692 (67.8%) 5742 (42.1%) 1 1
76–89 3312 (16.4%) 2159 (65.5%) 1.55 (1.41–1.72) 1.41 (1.29–1.53)
�75 3174 (15.7%) 2110 (73.5%) 1.75 (1.57–1.95) 1.53 (1.41–1.65)
Unknown 29 (0.1%)
Glasgow Coma Score (total)
Mild (13–15) 13842 (68.5%) 6499 (47.1%) 1 1
Moderate (9–12) 2704 (13.4%) 1536 (57.0%) 1.21 (1.04–1.41) 1.05 (0.92–1.19)
Severe (3–8) 3638 (18.0%) 2190 (60.5%) 1.28 (1.13–1.46) 1.11 (1.00–1.24)
Unknown 23 (0.1%)
Respiratory rate (per min)
<10 305 (1.5%) 207 (68.1%) 1.40 (1.11–1.77) 1.02 (0.76–1.38)
10–29 16791 (83.1%) 8117 (48.5%) 1 1
>29 2920 (14.5%) 1788 (61.6%) 1.27 (1.16–1.39) 1.08 (1.00–1.17)
Unknown 191 (1.0%)
Heart rate (beats per min)
<77 1746 (8.6%) 742 (42.8%) 1.15 (1.05–1.26) 1.06 (0.98–1.15)
77–91 3497 (17.3%) 1298 (37.2%) 1 1
92–107 5102 (25.3%) 2279 (44.9%) 1.21 (1.12–1.30) 1.16 (1.09–1.24)
>107 9725 (48.1%) 5804 (59.9%) 1.61 (1.45–1.79) 1.37 (1.25–1.51)
Unknown 137 (0.7%)
Central capillary refill time (s)
�2 6838 (33.8%) 3017 (44.3%) 1 1
(Continued)
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randomization was 3.4 hours, on average, with 48% of patients (9,585) in the�1 hour
group. 88% (17,625) of women delivered in the hospital. The frequencies of blood transfusion
for patients in high-income, upper-middle-income, lower-middle-income, and low-income
countries were 36%, 30%, 61%, and 40%, respectively. For women transfused with blood com-
ponents, transfusion volume differed by country income group (Fig 2). With decreasing coun-
try income level, the frequency of single unit blood component transfusions increased: high-
income (2%), upper-middle-income (25%), lower-middle-income (32%), and low-income
(39%). Age was a risk factor for blood transfusion in women with postpartum hemorrhage.
Relative to patients in the�25 year age category, patients in the>33 year age category had a
24% increased risk of blood transfusion. Childbirth outside of the hospital increased the risk of
blood component transfusion (RR 1.54; 95% CI 1.41–1.67). If time from delivery to randomi-
zation was >3 hours, the risk of blood transfusion increased, both for women who delivered
outside of the hospital (RR 1.26; 95% CI 1.05–1.52) and women who delivered inside of the
hospital (RR 1.14; 95% CI 1.03–1.26). Of the exposures investigated in the WOMAN trial, no
Table 1. (Continued)
Variable Total Blood component transfusion (% transfused) Crude risk ratio (95% CI) Adjusted risk ratio� (95% CI)
3–4 9387 (46.5%) 4746 (50.7%) 1.14 (0.95–1.38) 1.05 (0.90–1.22)
>4 3371 (16.7%) 2124 (63.3%) 1.43 (1.20–1.70) 1.13 (0.96–1.32)
Unknown 611 (3.0%)
�Adjusted variables include age, sex, time since injury, injury type, systolic blood pressure, Glasgow Coma Score, respiratory rate, heart rate, central capillary refill time,
and use of tranexamic acid
†Income group was defined according to the World Bank’s June 2017 classification system
https://doi.org/10.1371/journal.pone.0233274.t001
Fig 1. The frequency of blood transfusion volumes differs by country income group in traumatic hemorrhage
patients: high-income (A), upper-middle-income (B), lower-middle-income (C), and low-income (D).
https://doi.org/10.1371/journal.pone.0233274.g001
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risk factor had>1% missing data. In the WOMAN trial, only 43 (<1%) of trial participants
had missing outcome data.
After adjustment, there was strong evidence of an increase in transfusion likelihood in
lower-middle-income countries (ARR 1.55; 95% CI 1.30–1.85). However, this association dis-
appeared upon analysis of blood transfusions greater than one unit, and all risk ratios
decreased in magnitude (Table 4). When single unit blood transfusions were excluded, the
adjusted relative risk for lower-middle-income countries was 1.07 (95% CI 0.89–1.28), and
there was only evidence of a decrease in risk in low-income countries relative to high-income
countries (ARR 0.67; 95% CI 0.49–0.91). Lower country income level was associated with an
increased risk of single unit blood transfusion. Patients in lower-middle-income countries had
the greatest risk of single unit blood transfusion (ARR 24.40; 95% CI 13.82–43.07).
After controlling for severity of bleeding there was no association between maternal age
and the risk of transfusion. Childbirth outside of the hospital was associated with an increased
risk of transfusion (ARR 1.30; 95% CI 1.22–1.39). Adjusted risk ratios for increasing time since
childbirth indicated a moderate increase in transfusion likelihood in women >3 hours after
childbirth (ARR 1.09; 95% CI 1.01–1.17). While caesarean section increased the risk of transfu-
sion (ARR 1.16; 95% CI 1.08–1.25), incomplete expulsion of the placenta did not (ARR 1.00;
95% CI 0.95–1.06). All identifiable causes of hemorrhage–including surgical trauma or tears,
placenta previa or accreta, and other causes of hemorrhage–were associated with an increased
likelihood of transfusion relative to uterine atony. Amongst hemodynamic factors, blood loss
>1500 mL was associated with the greatest likelihood of transfusion (ARR 2.84; 95% CI 2.12–
3.78).
Discussion
For patients who suffered from traumatic hemorrhage, the only risk factor for transfusion,
other than variables indicative of hemodynamic status, is time since injury. Patients with post-
partum hemorrhage have an increased likelihood of transfusion with childbirth outside of the
hospital, increased time since childbirth, Caesarean section, and all identifiable causes of hem-
orrhage other than uterine atony. Our study shows that lower country income level is associ-
ated with lower transfusion likelihood in traumatic hemorrhage patients but is associated with
higher transfusion likelihood in postpartum hemorrhage patients. In women with postpartum
Table 2. Adjusted risk ratios for blood transfusion by country income group after traumatic hemorrhage.
Country income group† Crude risk ratio (95% CI) Adjusted risk ratio (95% CI)�
Outcome: >1 unit transfusion
High 1 1
Upper-middle 0.57 (0.48–0.68) 0.70 (0.57–0.86)
Lower-middle 0.46 (0.39–0.55) 0.55 (0.45–0.67)
Low 0.64 (0.60–0.68) 0.54 (0.45–0.64)
Outcome: 1 unit transfusion
High 1 1
Upper-middle 3.28 (1.04–10.31) 4.87 (1.85–12.80)
Lower-middle 4.91 (1.72–14.03) 6.24 (2.50–15.59)
Low 9.34 (3.35–26.03) 10.04 (4.06–24.82)
�Adjusted variables include age, sex, time since injury, injury type, systolic blood pressure, Glasgow Coma Score,
respiratory rate, heart rate, central capillary refill time, and use of tranexamic acid
†Income group was defined according to the World Bank’s June 2017 classification system
https://doi.org/10.1371/journal.pone.0233274.t002
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Table 3. Analysis of risk factors for blood transfusion in postpartum hemorrhage patients.
Variable Total Blood component transfusion (% transfused) Crude risk ratio (95% CI) Adjusted risk ratio� (95% CI)
Country income group†
High 569 (2.8%) 202 (35.8%) 1 1
Upper-middle 566 (2.8%) 168 (29.7%) 0.83 (0.40–1.72) 0.98 (0.47–2.05)
Lower-middle 14718
(73.4%)
8917 (60.7%) 1.69 (1.36–2.11) 1.55 (1.30–1.85)
Low 4207 (21.0%) 1671 (39.8%) 1.11 (0.86–1.44) 1.06 (0.84–1.33)
Age (years)
�25 6856 (34.2%) 3453 (50.5%) 1 1
26–33 9188 (45.8%) 5007 (54.6%) 1.08 (1.03–1.14) 0.98 (0.94–1.02)
>33 4009 (20.0%) 2498 (62.4%) 1.24 (1.16–1.32) 1.01 (0.96–1.06)
Unknown 7 (<0.1%)
Hospital childbirth
Yes 17625
(87.9%)
9039 (51.4%) 1 1
No 2432 (12.1%) 1917 (79.0%) 1.54 (1.41–1.67) 1.30 (1.22–1.39)
Unknown 3 (<0.1%)
Time from childbirth (h)
�1 9585 (47.8%) 4754 (49.7%) 1 1
>1–3 5369 (26.8%) 2892 (54.0%) 1.09 (0.99–1.19) 1.01 (0.94–1.09)
>3 5091 (25.4%) 3303 (65.0%) 1.31 (1.19–1.44) 1.09 (1.01–1.17)
Unknown 15 (<0.1%)
Type of childbirth
Vaginal childbirth 14219
(70.9%)
6990 (49.3%) 1 1
Caesarean section 5836 (29.1%) 3965 (68.1%) 1.38 (1.29–1.48) 1.16 (1.08–1.25)
Unknown 5 (<0.1%)
Placenta fully expelled
Yes 18105
(90.3%)
9603 (53.2%) 1 1
No 1952 (9.7%) 1353 (69.4%) 1.30 (1.21–1.41) 1.00 (0.95–1.06)
Unknown 3 (<0.1%)
Primary cause of hemorrhage
Uterine atony 12784
(63.7%)
6282 (49.2%) 1 1
Surgical trauma or tears 3691 (18.4%) 2107 (57.2%) 1.16 (1.07–1.26) 1.08 (1.01–1.15)
Placenta previa or accreta 1878 (9.4%) 1457 (77.8%) 1.58 (1.44–1.73) 1.19 (1.12–1.27)
Other 1457 (7.3%) 987 (67.9%) 1.38 (1.21–1.57) 1.19 (1.10–1.29)
Undetermined 246 (1.2%) 123 (50%) 1.02 (0.83–1.24) 0.95 (0.82–1.11)
Unknown 4 (<0.1%)
Systolic blood pressure (mmHg)
�90 16203
(80.8%)
8176 (50.5%) 1 1
76–89 2179 (10.9%) 1486 (68.5%) 1.36 (1.23–1.49) 1.07 (1.01–1.13)
�75 1673 (8.3%) 1295 (77.7%) 1.54 (1.38–1.71) 1.10 (1.04–1.16)
Unknown 5 (<0.1%)
Estimated blood loss (mL)
�500 608 (3.0%) 131 (21.6%) 1 1
>500 to�1000 9810 (48.9%) 3820 (39.0% 1.81 (1.37–2.37) 1.69 (1.30–2.20)
>1000 to�1500 5714 (28.5%) 3680 (64.5%) 2.99 (2.21–4.05) 2.39 (1.80–3.18)
(Continued)
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hemorrhage, these results are largely driven by the administration of single unit blood transfu-
sions. In postpartum hemorrhage patients, exclusion of single unit blood transfusions reduces
the risk of blood transfusion in all country income levels, relative to high-income countries.
Both studies were large, randomized placebo-controlled trials with minimal missing data.
The likelihood of information bias was low for blood transfusion because it is a well-recorded
outcome. However, measurement error may have occurred for some variables of interest like
systolic blood pressure, raising the possibility of residual confounding.
Both the CRASH-2 and WOMAN trials were designed to assess the effect of tranexamic
acid on patient outcomes, rather than to determine the risk factors for transfusion. Both stud-
ies did not collect data on some factors of interest, including blood availability and transfusion
Table 3. (Continued)
Variable Total Blood component transfusion (% transfused) Crude risk ratio (95% CI) Adjusted risk ratio� (95% CI)
>1500 3926 (19.6%) 3327 (85.1%) 3.94 (2.88–5.39) 2.84 (2.12–3.78)
Unknown 2 (<0.1%)
Clinical signs of hemodynamic
instability
No 8200 (40.9%) 3075 (37.5%) 1 1
Yes 11859
(59.1%)
7883 (66.7%) 1.78 (1.50–2.11) 1.43 (1.24–1.64)
Unknown 1 (<0.1%)
�Adjusted variables include country income group, age, hospital childbirth, time from childbirth, type of childbirth, placenta fully expelled, primary cause of
hemorrhage, systolic blood pressure, estimated blood loss, clinical signs of hemodynamic instability, and use of tranexamic acid
†Income group was defined according to the World Bank’s June 2017 classification system
https://doi.org/10.1371/journal.pone.0233274.t003
Fig 2. The frequency of blood transfusion volumes differs by country income group in postpartum hemorrhage
patients: high-income (A), upper-middle-income (B), lower-middle-income (C), and low-income (D).
https://doi.org/10.1371/journal.pone.0233274.g002
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practices. Country income level was a proxy for these unrecorded factors [28,29]. In future
studies, recording data on more specific factors, that vary by country income level, would help
reveal why transfusion likelihood differs by country income group.
We used log-link robust Poisson regression in this study for several reasons. First, such
models allow for the direct assessment of risk ratios. Odds ratios may have overestimated the
effect measures in this study due to the high incidence of blood transfusions. Second, binomial
models for estimating relative risks often do not converge [26]. While we opted for a robust
Poisson regression model in this study, the use of Poisson regression is known to produce con-
servative confidence intervals, suggesting that the true confidence intervals for the risk ratios
would likely be narrower than those estimated.[30]
A stepwise approach was taken to generate multivariate Poisson regression models that
accounted for confounders. We also adjusted for clustering at the hospital level. Even still,
unmeasured confounding may account for some of this study’s results. While we controlled
for a number of factors relevant to severity of bleeding, residual confounding may still exist.
Importantly, data on hemoglobin level were not obtained for either trial. Hemoglobin level is
frequently used as a threshold marker for the initiation of blood transfusions [29,31]. While
hemoglobin levels are typically known for patients in high income countries, these data are not
always available in low income countries. However, in cases of acute hemorrhage, hemoglobin
level is often not an appropriate indicator for transfusion [32].
Instead, hemodynamic factors tend to guide transfusion practices in both trauma and post-
partum hemorrhage patients. Studies of blood transfusions in trauma settings suggest that
patients with elevated blood pressures and normal heart rates are less likely to receive blood
transfusions, including massive transfusions (greater than or equal to ten units of blood)
[33,34]. This finding is influenced by the fact that, in settings of acute trauma, decisions to
transfuse are often driven by the use of scoring systems like the shock index (defined as heart
rate divided by systolic blood pressure). For women with postpartum hemorrhage, the deci-
sion to transfuse typically depends on estimated blood loss�500 mL, rising pulse, and decreas-
ing blood pressure, as long as a reversible cause of hemorrhage is not confirmed [35]. If a
cause of hemorrhage is identified, reversal of the underlying cause of hemorrhage is attempted
prior to transfusion. Because hemodynamic variables are used as indicators to initiate blood
Table 4. Adjusted risk ratios for blood transfusion by country income group after postpartum hemorrhage.
Country income group† Crude risk ratio (95% CI) Adjusted risk ratio� (95% CI)
Outcome: >1 unit transfusion
High 1 1
Upper-middle 0.63 (0.34–1.18) 0.84 (0.45–1.57)
Lower-middle 1.18 (0.92–1.51) 1.07 (0.89–1.28)
Low 0.69 (0.49–0.97) 0.67 (0.49–0.91)
Outcome: 1 unit transfusion
High 1 1
Upper-middle 10.46 (3.13–35.00) 9.50 (2.81–32.11)
Lower-middle 27.09 (15.18–48.36) 24.40 (13.82–43.07)
Low 21.89 (11.98–39.99) 19.36 (10.77–34.80)
�Adjusted variables include age, hospital childbirth, time from childbirth, type of childbirth, placenta fully expelled,
primary cause of hemorrhage, systolic blood pressure, estimated blood loss, clinical signs of hemodynamic instability,
and use of tranexamic acid
†Income group was defined according to the World Bank’s June 2017 classification system
https://doi.org/10.1371/journal.pone.0233274.t004
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transfusions in both trauma and postpartum hemorrhage patients, it is not surprising that our
findings–that hemodynamically unstable patients are more likely to be transfused– are consis-
tent with previous work.
Likewise, our finding of less frequent large-volume blood transfusions in countries of lower
income are consistent with other reports [36–38]. The availability and safety of blood compo-
nents affects blood transfusion rates. The World Health Organization recommends a blood
donation rate of at least 10 units per 1000 people per year. Currently, however, many countries
do not meet minimum recommended donation rates. In high-income, upper-middle-income,
lower-middle-income, and low-income countries, blood donation rates are 32.1, 14.9, 7.8, and
4.6 donations per 1000 people per year, respectively [15]. Due to low blood donation rates and
high population prevalence rates of transfusion-transmissible infections, many low- and mid-
dle-income countries are unable to meet transfusion demand.
Differences in anemia may help explain the different transfusion practices in traumatic and
postpartum hemorrhage. Anemia is more prevalent in pregnant women than non-pregnant
women and is more prevalent in low-income settings than high-income settings [39]. Globally,
33% of non-pregnant women are anemic, and 40% of pregnant women are anemic, with sig-
nificant variability by region [40,41]. One study, conducted in Southeast Asia, found that 80%
of pregnant women and 60% of non-pregnant women were anemic [42]. For postpartum hem-
orrhage patients in low-income settings, low-volume blood transfusions may be used to simul-
taneously treat both acute postpartum hemorrhage and prevalent anemia [43–46].
For lower-middle-income countries in the WOMAN trial, limited blood supplies likely led
to the frequent administration of single unit blood transfusions, despite the need for higher
volume transfusions [47]. Most patients in the lower-middle-income country category were
from Nigeria and Pakistan. One study found that many obstetric patients at one of the trial
sites–University College Hospital, Ibadan–received single unit blood transfusions despite the
need for additional units, based on estimated blood loss or low hematocrit values [48,49]. Simi-
larly, in Pakistan, a 40% shortage of blood and blood components limits the amount of
donated blood available for transfusion [50]. The higher frequency of single unit transfusions
in low income countries may be driven by both lower blood donation rates and the higher fre-
quency of anemia in low income countries. While restrictive transfusion practices in a range of
settings have been shown to be beneficial, single unit transfusions may be insufficient to treat
patients suffering from severe traumatic and postpartum hemorrhage [51–53].
Both increased time from trauma to hospitalization and increased time from childbirth to
hospitalization increased the likelihood of transfusion. One explanation for these results may
be that indicators of extended hypoperfusion, like tissue ischemia, are unaccounted for by
measuring traditional hemodynamic factors such as blood pressure, leading to residual con-
founding. We also found that Caesarean section was associated with an increased risk of blood
transfusion. One possible reason for this observation may be that Caesarean sections tend to
be performed during more complicated pregnancies, where hemodynamic stability is compro-
mised by additional pathology. Another possibility is that Caesarean sections are necessary
due to insufficiently controlled bleeding. Factors that increase the likelihood of Caesarean sec-
tion include placenta previa, fetal distress, breech presentation, and macrosomia [54,55]. We
also found evidence that identifiable causes of hemorrhage other than uterine atony, including
surgical trauma or tears, placenta previa or accreta, and other causes of hemorrhage, increased
the likelihood of blood component transfusion. Differences in transfusion likelihood amongst
causes of hemorrhage may relate to the effectiveness of managing bleeding arising from differ-
ent causes. For example, for postpartum hemorrhage due to uterine atony, uterotonics are a
first line treatment, and sometimes transfusion may be avoided by successful uterotonic inter-
vention [56,57].
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Conclusions
Our study found that, for patients who suffered from traumatic hemorrhage, risk factors for
transfusion were time since injury, country income level, and hemodynamic factors, including
systolic blood pressure and heart rate. Patients with postpartum hemorrhage have an increased
likelihood of transfusion with childbirth outside of the hospital, increased time since giving
birth, Caesarean section, birth in lower-middle income countries, and all identifiable causes of
hemorrhage other than uterine atony. Hemodynamic factors, including systolic blood pres-
sure, estimated blood loss, and clinical signs of hemodynamic instability, were also associated
with increased likelihood of transfusion in postpartum hemorrhage patients. The findings of
this study have clinical implications. Altering modifiable factors, by reducing time from injury
or childbirth to hospitalization, could reduce blood transfusions and complications associated
with transfusions. Future studies should investigate subgroup analyses of the various factors
that contribute to the association between risk factors and transfusion.
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